Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMP-656 in HER2-Positive Advanced Breast Cancer
NCT07726342Phase 2Recruiting
- Sponsor
- SciMount Pharmatech, Co. Ltd.
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SMP-656 in breast cancer, sponsored by SciMount Pharmatech, Co. Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
SMP-656
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07726342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07726342.